$131.00
-7.01[-5.08%]
At close: Apr 26
$131.00
0[0.00%]
PreMarket: 7:16AM EDT
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
Date Announced | ticker | Company Name | Period | Period Year | Min EPS | Max EPS | Estimate | Min Rev | Max Rev | Revenue Estimate | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|
04/25/2024 | DXCM | DexCom | FY | 2024 | — | — | — | $4.20B | $4.35B | $4.33B | Get Alert |
02/08/2024 | DXCM | DexCom | FY | 2024 | — | — | — | $4.15B | $4.35B | $4.33B | Get Alert |
01/08/2024 | DXCM | DexCom | FY | 2024 | — | — | — | $4.15B | $4.35B | $4.32B | Get Alert |
01/08/2024 | DXCM | DexCom | FY | 2023 | — | — | — | $3.62B | $3.62B | $3.59B | Get Alert |
01/08/2024 | DXCM | DexCom | Q4 | 2023 | — | — | — | $1.03B | — | $1.01B | Get Alert |
10/26/2023 | DXCM | DexCom | FY | 2023 | — | — | — | $3.58B | $3.60B | $3.54B | Get Alert |
09/06/2023 | DXCM | DexCom | FY | 2023 | — | — | — | $3.50B | $3.55B | $3.54B | Get Alert |
07/27/2023 | DXCM | DexCom | FY | 2023 | — | — | — | $3.50B | $3.55B | $3.50B | Get Alert |
06/26/2023 | DXCM | DexCom | FY | 2025 | — | — | — | $4.60B | $5.10B | — | Get Alert |
04/27/2023 | DXCM | DexCom | FY | 2023 | — | — | — | $3.40B | $3.52B | $3.47B | Get Alert |
02/09/2023 | DXCM | DexCom | FY | 2023 | — | — | — | $3.35B | $3.49B | $3.47B | Get Alert |
01/09/2023 | DXCM | DexCom | FY | 2023 | — | — | — | $3.35B | $3.49B | $3.47B | Get Alert |
01/09/2023 | DXCM | DexCom | FY | 2022 | — | — | — | $2.91B | $2.91B | $2.90B | Get Alert |
01/09/2023 | DXCM | DexCom | Q4 | 2022 | — | — | — | $815.00M | — | $807.65M | Get Alert |
10/27/2022 | DXCM | DexCom | FY | 2022 | — | — | — | $2.88B | $2.91B | $2.89B | Get Alert |
07/28/2022 | DXCM | DexCom | FY | 2022 | — | — | — | $2.86B | $2.91B | $2.92B | Get Alert |
04/28/2022 | DXCM | DexCom | FY | 2022 | — | — | — | $2.82B | $2.94B | $2.92B | Get Alert |
02/10/2022 | DXCM | DexCom | FY | 2022 | — | — | — | $2.82B | $2.94B | $2.96B | Get Alert |
01/10/2022 | DXCM | DexCom | Q4 | 2021 | — | — | — | $698.00M | $698.00M | $696.47M | Get Alert |
There have been no specific sales or earnings guidance reported for DexCom in recent months.
Browse guidance and forecast on all stocks.